Managing Risk of Dysplasia and Colorectal Cancer in Inflammatory Bowel Disease

IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Techniques and Innovations in Gastrointestinal Endoscopy Pub Date : 2023-01-01 DOI:10.1016/j.tige.2023.02.005

Juan Reyes Genere, Parakkal Deepak

{"title":"Managing Risk of Dysplasia and Colorectal Cancer in Inflammatory Bowel Disease","authors":"Juan Reyes Genere, Parakkal Deepak","doi":"10.1016/j.tige.2023.02.005","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Mitigating colorectal cancer (CRC) risk is a pillar in caring for patients with inflammatory bowel disease (IBD). Over the last decade, there have been significant advances in understanding the natural history of colitis-associated dysplasia (CAD) and its management. The identification of patient- and disease-specific risk factors has enabled a tailored approach to initiating </span>colonoscopy screening and surveillance programs. Improved video </span>endoscopy<span> systems and the development of advanced endoscopic resection techniques have evolved the role of endoscopy in CAD. Modern-era endoscopic instruments can better detect and effectively intervene with CAD, reducing CRC risk. As a result, the last decade has brought forth substantial changes to how endoscopic technologies are applied to IBD surveillance. This review will go over the latest updates in the stratification and management of CAD and CRC risk for patients with IBD, as well as discuss the exciting future in this topic area.</span></p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Techniques and Innovations in Gastrointestinal Endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590030723000235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Mitigating colorectal cancer (CRC) risk is a pillar in caring for patients with inflammatory bowel disease (IBD). Over the last decade, there have been significant advances in understanding the natural history of colitis-associated dysplasia (CAD) and its management. The identification of patient- and disease-specific risk factors has enabled a tailored approach to initiating colonoscopy screening and surveillance programs. Improved video endoscopy systems and the development of advanced endoscopic resection techniques have evolved the role of endoscopy in CAD. Modern-era endoscopic instruments can better detect and effectively intervene with CAD, reducing CRC risk. As a result, the last decade has brought forth substantial changes to how endoscopic technologies are applied to IBD surveillance. This review will go over the latest updates in the stratification and management of CAD and CRC risk for patients with IBD, as well as discuss the exciting future in this topic area.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

炎症性肠病中发育不良和结直肠癌癌症的风险管理

减轻癌症（CRC）风险是治疗炎症性肠病（IBD）患者的支柱。在过去的十年里，在了解结肠炎相关发育不良（CAD）的自然史及其治疗方面取得了重大进展。患者和疾病特异性风险因素的识别为启动结肠镜检查筛查和监测计划提供了一种量身定制的方法。改进的视频内窥镜系统和先进的内窥镜切除技术的发展使内窥镜在CAD中的作用得到了发展。现代内镜仪器可以更好地检测和有效干预CAD，降低CRC风险。因此，在过去的十年里，内窥镜技术应用于IBD监测的方式发生了重大变化。这篇综述将介绍IBD患者CAD和CRC风险的分层和管理的最新进展，并讨论该主题领域令人兴奋的未来。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助